Clinical Trial Update: Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a tumor vaccine used as adjuvant therapy after radical operation in lung cancer patients, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Tumor vaccine (tumor vaccine)

Snippet

Sponsor: Yongchang Zhang | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN